Journal ArticleAm J Surg · July 2024
BACKGROUND: The predictive and prognostic value of the recurrence score (RS) has emphasized the importance of tumor biology and has reduced the prognostic implications of limited nodal burden in post-menopausal women with HR+/HER2-invasive breast cancer (I ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · May 10, 2024
PURPOSE: Black women have higher rates of death from triple-negative breast cancer (TNBC) than White women. We hypothesized that pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) and overall survival (OS) may vary by race/ethnicity in pa ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · April 2024
Rates of contralateral mastectomy (CM) among patients with unilateral breast cancer have been increasing in the United States. In this Society of Surgical Oncology position statement, we review the literature addressing the indications, risks, and benefits ...
Full textLink to itemCite
Journal ArticleThe American Surgeon™ · July 2018
To determine whether low-income status as demonstrated by insurance type has any association with aggressive tumor biology and breast cancer outcomes. Retrospective review of 535 women with new diagnosis of breast cancer from January 2009 to March ...
Full textCite
Chapter · September 1, 2017
The book chapter addresses the complex multidisciplinary management of lororegional recurrence (LRR), breast cancer in the augmented breast and breast cancer risk in the contralateral breast ...
Cite
Journal ArticleJournal of Clinical Investigation · November 1, 2013
Therapeutic drugs with ototoxic side effects cause significant hearing loss for thousands of patients annually. Two major classes of ototoxic drugs are cisplatin and the aminoglycoside antibiotics, both of which are toxic to mechanosensory hair cells, the ...
Full textCite